Characterization of the in vitro metabolites of idelalisib in liver microsomes and interspecies comparison
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference19 articles.
1. The role of phosphatidylinositol 3-kinase-delta in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia;Herman;Blood,2011
2. CAL-101, a p110 delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability;Lannuttiet;Blood,2011
3. The phosphoinositide 3’-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia;Hoellenriegel;Blood,2011
4. Idelalisib for relapsed/refractory indolent B-cell non-Hodgkin’s lymphoma: an overview of pharmacokinetics and clinical trial outcomes;Davies;Expert Rev. Hematol.,2015
5. Idelalisib: first global approval;Markham;Drugs,2014
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition;Translational Oncology;2024-05
2. Targeting T regulatory (Treg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12
3. Pharmacokinetics and in vitro liver microsomal enzyme metabolism of Xylopic acid;Journal of Pharmaceutical and Biomedical Analysis;2023-02
4. UHPLC–Q‐TOF–MS/MS‐based metabolite profiling of duvelisib and establishment of its metabolism mechanisms;Biomedical Chromatography;2022-01-14
5. Hepatotoxicity of FDA-approved small molecule kinase inhibitors;Expert Opinion on Drug Safety;2020-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3